Trials / Completed
CompletedNCT01025063
Use of Spectral OCT in Combination Therapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- Barnes Retina Institute · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study will investigate the safety and efficacy of treatment of choroidal neovascularization (CNV) due to age-related macular degeneration (AMD) with a combination of ranibizumab (Lucentis) and verteporfin PDT (Visudyne), as compared with ranibizumab monotherapy.
Conditions
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2009-12-03
- Last updated
- 2017-10-30
Source: ClinicalTrials.gov record NCT01025063. Inclusion in this directory is not an endorsement.